Evidence map›Paper›PMID 33510427›Full record

ArticleScientific reports2021

HLA-DRB1 allelic epitopes that associate with autoimmune disease risk or protection activate reciprocal macrophage polarization.

Vincent van Drongelen, Bruna Miglioranza Scavuzzi, Sarah Veloso Nogueira, Frederick W Miller, Amr H Sawalha, Joseph Holoshitz

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe?Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. HLA-G and the MHC Cusp Theory.Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Vincent van DrongelenDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Bruna Miglioranza ScavuzziDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Sarah Veloso NogueiraDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Frederick W MillerEnvironmental Autoimmunity Group, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, 27709, USA.
Amr H SawalhaDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Joseph HoloshitzDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. jholo@med.umich.edu.
University of Michigan–Ann Arbor · USNational Institute of Environmental Health Sciences · USUniversity of Pittsburgh · US

Funding

Environmental/genetic Risk Factors and Pathogenesis of Autoimmune DiseaseZIAES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$34.6M
Immune Modulating HLA-Coded Ligands in Rheumatoid ArthritisR01AR059085 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLOSHITZ, JOSEPH · 2011 to 2020
$3.8M
Gene-environment interaction pathways in rheumatoid arthritisR01AR074930 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLOSHITZ, JOSEPH · 2019 to 2023
$2.6M
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseasesR61AR073014 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLOSHITZ, JOSEPH · 2017 to 2018
$770k
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseasesR33AR073014 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLOSHITZ, JOSEPH · 2019 to 2019
$390k
NIAMS NIH HHS R01 AR059085NIAMS NIH HHS R01AR059085NIAMS NIH HHS R01 AR074930NIAMS NIH HHS R33 AR073014NIAMS NIH HHS R61 AR073014NIAMS NIH HHS R61AR073014NIEHS NIH HHS HHSN273201600123P
6 · The paper itself

Abstract

Associations between particular human leukocyte antigen (HLA) alleles and susceptibility to-or protection from-autoimmune diseases have been long observed. Allele-specific antigen presentation (AP) has been widely proposed as a culprit, but it is unclear whether HLA molecules might also have non-AP, disease-modulating effects. Here we demonstrate differential macrophage activation by HLA-DRB1 alleles known to associate with autoimmune disease risk or protection with resultant polarization of pro-inflammatory ("M1") versus anti-inflammatory ("M2") macrophages, respectively. RNA-sequencing analyses of in vitro-polarized macrophages in the presence of AP-incompetent short synthetic peptides corresponding to the third allelic hypervariable regions coded by those two HLA-DRB1 alleles showed reciprocal activation of pro- versus anti-inflammatory transcriptomes, with implication of corresponding gene ontologies and upstream regulators. These results identify a previously unrecognized mechanism of differential immune modulation by short HLA-DRB1-coded allelic epitopes independent of AP, and could shed new light on the mechanistic basis of HLA-disease association.

Indexed as

AnimalsAutoimmune DiseasesCells, CulturedEpitopesFlow CytometryHLA-DRB1 ChainsImmunoblottingMacrophage ActivationMaleMiceMice, TransgenicRAW 264.7 CellsRNA-SeqEpitopesHLA-DRB1 Chains

Identifiers

PMID33510427
PMCPMC7844024
OpenAlexW3124248449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.